Li Mao

23.3k citations
363 papers · 19.3k · 4 hit papers · h-index 69

Impact in

Papers in

    • Cancer-related Molecular Pathways 26
    • Pancreatic and Hepatic Oncology Research 13
    • RNA modifications and cancer 33
    • Epigenetics and DNA Methylation 32
    • Cancer-related gene regulation 19

Li Mao

350 papers receiving 18.7k citations

Li Mao's Hit Papers

The BATTLE Trial: Personalizing Therapy for Lung Cancer 2011 · 702 citations
7020+10+20Years since publication50010001.5k

Peers

Li Mao
Comparison fields: 5 of 193
  • Otorhinolaryngology 1.4k
  • Cancer Research 3.5k
  • Periodontics 916
  • Oncology 5.4k
  • Molecular Biology 9.5k
Replace Wan Ling Lam with:
Wan Ling Lam Canada
Qingyi Wei United States
Keitaro Matsuo Japan
David Georgievich Zaridze France
Ezra E.W. Cohen United States
Fei‐Fei Liu Canada
Dana Mateș France
Vassilis G. Gorgoulis Greece
Marc T. Goodman United States
Gregory T. Wolf United States
Li Mao relative to Wan Ling Lam Canada Wan Ling Lam's profile →
Citations per field
00.5×2×2.5×
Wan Ling Lam · 1×
Citations per year

Countries citing papers authored by Li Mao

Since Specialization
Citations

This map shows the geographic impact of Li Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Mao more than expected).

Fields of papers citing papers by Li Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Mao. The network helps show where Li Mao may publish in the future.

Co-authors

The 25 scholars most cited alongside Li Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Li Mao Line = papers co-authored together Li Mao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 363 papers — load more, or switch the sort, to bring in the rest.

#Work
1
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
Hit paper breakdown →
19951743
2
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
Hit paper breakdown →
19951196
3
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Hit paper breakdown →
2011702
4
Molecular Assessment of Histopathological Staging in Squamous-Cell Carcinoma of the Head and Neck
Hit paper breakdown →
1995639
5 1996454
6 1994391
7
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
2002359
8
Predicting cancer development in oral leukoplakia: ten years of translational research.
2000338
9 2007331
10 2004316
11 2008288
12
Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
2000265
13 2006260
14 2007249
15 2009247
16 2004222
17 2019190
18 2020184
19 2008176
20 2012175

About Li Mao

Li Mao is a scholar working on Oncology, Molecular Biology, Cancer Research, Otorhinolaryngology and Immunology, having authored 363 papers that have together received 19.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (33 papers), Epigenetics and DNA Methylation (32 papers), Cancer-related Molecular Pathways (26 papers), Cancer-related gene regulation (19 papers), Head and Neck Cancer Studies (18 papers), MicroRNA in disease regulation (15 papers), Pancreatic and Hepatic Oncology Research (13 papers) and Lung Cancer Treatments and Mutations (12 papers). The work is most often cited by research in Otorhinolaryngology (1.4k citations), Cancer Research (3.5k citations), Periodontics (916 citations), Oncology (5.4k citations) and Molecular Biology (9.5k citations). Li Mao has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Waun Ki Hong, David Sidransky, Adrian Ulrico Merlo, James Gordon Herman, Stephen B. Baylin, Daniel J. Lee, Jean‐Pierre J. Issa, Adel K. El‐Naggar, Peter C. Burger and Edward W. Gabrielson. Their work appears in journals such as Clinical Cancer Research, Cancer Prevention Research, Cancer Research, Oncogene and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact